Dopamine in the hippocampus is cleared by the norepinephrine transporter

International Journal of Neuropsychopharmacology

Volumn 15, Issue 4, 2012, Pages 531-540

  Borgkvist, Anders ^a   Malmlöf, Torun ^a   Feltmann, Kristin ^a   Lindskog, Maria ^a   Schilström, Björn ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amphetamine; antidepressant; cocaine; dopamine transporter; microdialysis; rat

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMPHETAMINE; ATOMOXETINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; IDAZOXAN; NOMIFENSINE; NORADRENALIN TRANSPORTER; RACLOPRIDE; REBOXETINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 84862679219     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000812     Document Type: Article

References (50)

1. Adcock RA, Thangavel A, Whitfield-Gabrieli S, Knutson B, et al. (2006). Reward-motivated learning: mesolimbic activation precedes memory formation. Neuron 50, 507-517.
2. Bischoff S, Scatton B, Korf J (1979). Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Research 165, 161-165. (Pubitemid 9133275)
3. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699-711. (Pubitemid 35335888)
4. Carboni E, Silvagni A, Vacca C, Di Chiara G (2006). Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. Journal of Neurochemistry 96, 473-481.
5. Carboni E, Tanda GL, Frau R, Di Chiara G (1990). Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. Journal of Neurochemistry 55, 1067-1070.
6. Carter AJ (1997). Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors. Journal of Pharmacology and Experimental Therapeutics 281, 648-654. (Pubitemid 27203795)
7. Chung Y-C, Li Z, Dai J, Meltzer HY, et al. (2004). Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism. Brain Research 1023, 54-63. (Pubitemid 39195334)
8. Devoto P, Flore G, Pani L, Gessa GL (2001). Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Molecular Psychiatry 6, 657-664. (Pubitemid 33020584)
9. Devoto P, Flore G, Saba P, Castelli MP, et al. (2008). 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex. Journal of Neuroscience Research 86, 1647-1658. (Pubitemid 351642458)
10. Di Chiara G, Tanda G, Carboni E (1996). Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity. Behavioural Pharmacology 7, 640-657. (Pubitemid 27151851)
11. Frey U, Schroeder H, Matthies H (1990). Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Research 522, 69-75. (Pubitemid 20208786)
12. Gasbarri A, Sulli A, Innocenzi R, Pacitti C, et al. (1996). Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience 74, 1037-1044. (Pubitemid 26313347)
13. Gasbarri A, Verney C, Innocenzi R, Campana E, et al. (1994). Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Research 668, 71-79.
14. Gehlert DR, Schober DA, Gackenheimer SL (1995). Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain. Journal of Neurochemistry 64, 2792-2800.
15. Giros B, Wang YM, Suter S, McLeskey SB, et al. (1994). Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. Journal of Biological Chemistry 269, 15985-15988. (Pubitemid 24209280)
16. Goldsmith SK, Joyce JN (1994). Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4, 354-373. (Pubitemid 24342369)
17. Guiard BP, El Mansari M, Blier P (2008). Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Molecular Pharmacology 74, 1463-1475.
18. Hertel P, Nomikos GG, Svensson TH (1999). Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. European Journal of Pharmacology 371, 153-158. (Pubitemid 29216997)
19. Huang Q, Zhou D, Chase K, Gusella JF, et al. (1992). Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre-and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proceedings of the National Academy of Sciences USA 89, 11988-11992. (Pubitemid 23004770)
20. Imperato A, Obinu MC, Gessa GL (1993). Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Research 618, 341-345. (Pubitemid 23207979)
21. Iversen L (2006). Neurotransmitter transporters and their impact on the development of psychopharmacology. British Journal of Pharmacology 147 (Suppl. 1), S82-88. (Pubitemid 43077265)
22. Kwon OB, Paredes D, Gonzalez CM, Neddens J, et al. (2008). Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proceedings of the National Academy of Sciences USA 105, 15587-15592.
23. Li S, Cullen WK, Anwyl R, Rowan MJ (2003). Dopaminedependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nature Neuroscience 6, 526-531. (Pubitemid 36514701)
24. Linnér L, Endersz H, Ohman D, Bengtsson F, et al. (2001). Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. Journal of Pharmacology and Experimental Therapeutics 297, 540-546. (Pubitemid 32377983)
25. Lisman JE, Otmakhova NA (2001). Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine. Hippocampus 11, 551-568. (Pubitemid 33100376)
26. Lorang D, Amara SG, Simerly RB (1994). Cell-type-specific expression of catecholamine transporters in the rat brain. Journal of Neuroscience 14, 4903-4914. (Pubitemid 24237912)
27. Marshall DL, Redfern PH, Wonnacott S (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. Journal of Neurochemistry 68, 1511-1519. (Pubitemid 27133058)
28. Mennicken F, Savasta M, Peretti-Renucci R, Feuerstein C (1992). Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. Journal of Neural Transmission. General Section 87, 1-14.
29. Montezinho LP, Miller S, Plath N, Jensen NH, et al. (2010). The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine. Psychopharmacology 212, 131-143.
30. Morón JA, Brockington A, Wise RA, Rocha BA, et al. (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. Journal of Neuroscience 22, 389-395. (Pubitemid 34049076)
31. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1990). In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6, 106-112. (Pubitemid 20270704)
32. Otmakhova NA, Lisman JE (1996). D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. Journal of Neuroscience 16, 7478-7486. (Pubitemid 26389686)
33. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. London: Academic Press.
34. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, et al. (1994). Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. Journal of Neurochemistry 63, 195-200. (Pubitemid 24184918)
35. Rahman S, Engleman E, Simon J, McBride WJ (2001). Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens. European Journal of Pharmacology 414, 37-44. (Pubitemid 32174873)
36. Raiteri M, Del Carmine R, Bertollini A, Levi G (1977). Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. European Journal of Pharmacology 41, 133-143. (Pubitemid 8015308)
37. Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D (2003). Presynaptic regulation of dopaminergic neurotransmission. Journal of Neurochemistry 87, 273-289. (Pubitemid 37255235)
38. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, et al. (2000). Immunolocalization of the cocaine-and antidepressant-sensitive L-norepinephrine transporter. Journal of Comparative Neurology 420, 211-232. (Pubitemid 30185979)
39. Sesack SR, Hawrylak VA, Matus C, Guido MA, et al. (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. Journal of Neuroscience 18, 2697-2708. (Pubitemid 28141815)
40. Smolders I, Clinckers R, Meurs A, De Bundel D, et al. (2008). Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action. Neuropharmacology 54, 1017-1028.
41. Tejani-Butt SM (1992). [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. Journal of Pharmacology and Experimental Therapeutics 260, 427-436.
42. Toth E, Vizi ES, Lajtha A (1993). Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32, 827-832. (Pubitemid 23227669)
43. Venton BJ, Zhang H, Garris PA, Phillips PEM, et al. (2003). Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. Journal of Neurochemistry 87, 1284-1295. (Pubitemid 37485084)
44. Verney C, Baulac M, Berger B, Alvarez C, et al. (1985). Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 14, 1039-1052. (Pubitemid 15114549)
45. Wall SC, Gu H, Rudnick G (1995). Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Molecular Pharmacology 47, 544-550.
46. Wittmann BC, Bunzeck N, Dolan RJ, Düzel E (2007). Anticipation of novelty recruits reward system and hippocampus while promoting recollection. Neuroimage 38, 194-202. (Pubitemid 47429984)
47. Wittmann BC, Schott BH, Guderian S, Frey JU, et al. (2005). Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 45, 459-467. (Pubitemid 40188212)
48. Wong EH, Sonders MS, Amara SG, Tinholt PM, et al. (2000). Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biological Psychiatry 47, 818-829. (Pubitemid 30254055)
49. Xu K, Näveri L, Frerichs KU, Hallenbeck JM, et al. (1993). Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. Journal of Pharmacology and Experimental Therapeutics 267, 211-217. (Pubitemid 23325010)
50. Yamamoto BK, Novotney S (1998). Regulation of extracellular dopamine by the norepinephrine transporter. Journal of Neurochemistry 71, 274-280. (Pubitemid 28292559)